Thermo Fisher Scientific
TMO
1,056 hedge funds and large institutions have $51.4B invested in Thermo Fisher Scientific in 2016 Q2 according to their latest regulatory filings, with 79 funds opening new positions, 384 increasing their positions, 421 reducing their positions, and 38 closing their positions.
108% more first-time investments, than exits
New positions opened: 79 | Existing positions closed: 38
34% more call options, than puts
Call options by funds: $233M | Put options by funds: $174M
3% more funds holding
Funds holding: 1,025 → 1,056 (+31)
1% more funds holding in top 10
Funds holding in top 10: 77 → 78 (+1)
4% more capital invested
Capital invested by funds: $49.3B → $51.4B (+$2.1B)
0.81% more ownership
Funds ownership: 87.91% → 88.72% (+0.81%)
9% less repeat investments, than reductions
Existing positions increased: 384 | Existing positions reduced: 421
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SSM
Sound Shore Management
Greenwich,
Connecticut
|
+$180M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$123M |
| 3 |
CG
Carmignac Gestion
Paris,
France
|
+$113M |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$97.6M |
| 5 |
JP Morgan Chase
New York
|
+$88.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$182M |
| 2 |
GCM
Glenview Capital Management
New York
|
-$111M |
| 3 |
EIG
EdgePoint Investment Group
Toronto,
Ontario, Canada
|
-$97.2M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$88.7M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
-$73.3M |
TMO Hedge Fund Activity: Q2 2016 in Review
1,056 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q2 2016, worth a combined $51.4B — up 4.3% from $49.3B a quarter earlier.
Buyers outnumbered sellers: 79 funds opened new TMO positions and 38 closed out — a net gain of 41 holders — while 384 added to existing stakes and 421 trimmed.
The largest buyer was Sound Shore Management, adding an estimated $180M. The largest seller was T. Rowe Price Associates, cutting an estimated $182M.
- 1,056 institutional investors held Thermo Fisher Scientific (TMO) as of Q2 2016, up from 1,025 in Q1 2016.
- Funds reported $51.4B of Thermo Fisher Scientific stock for Q2 2016, up 4.3% quarter-over-quarter.
- 79 funds opened new Thermo Fisher Scientific positions in Q2 2016 and 38 closed out, a net change of +41 holders.
- The largest Thermo Fisher Scientific buyer in Q2 2016 was Sound Shore Management, an estimated $180M added.
- The largest Thermo Fisher Scientific seller in Q2 2016 was T. Rowe Price Associates, an estimated $182M sold.
Based on aggregated 13F filings for Q2 2016.